Structural and Biochemical Properties of Fibroblast Growth Factor 23
- 19 July 2005
- journal article
- review article
- Published by Wiley in Therapeutic Apheresis and Dialysis
- Vol. 9 (4) , 313-318
- https://doi.org/10.1111/j.1744-9987.2005.00288.x
Abstract
Fibroblast growth factor (FGF) 23 shares a fundamentally common structure with the members of the FGF family and has a unique sequence extension at the C‐terminus. The molecular behavior of FGF23 as a systemic factor can be justified by the altered conformation of the β‐trefoil structure similar to that suspected in FGF19. On the other hand, the biological activity of FGF23 is quite distinct from those of other FGFs and requires the C‐terminal unique extended structure. Two types of enzyme‐linked immunosorbent assays (ELISA) have been developed to detect the intact mature form of FGF23 and its C‐terminal portion. The former ELISA method enables the detection of rodent FGF23 and human FGF23. Studies on experimental animal models and laboratory examinations of physiologic and disordered conditions using these assays are contributing toward elucidating the physiology and pathophysiology of FGF23.Keywords
This publication has 35 references indexed in Scilit:
- Fibroblast Growth Factor 23, Parathyroid Hormone, and 1α,25-Dihydroxyvitamin D in Surgically Treated Primary HyperparathyroidismMayo Clinic Proceedings, 2004
- Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient miceMatrix Biology, 2004
- Total parathyroidectomy reduces elevated circulating fibroblast growth factor 23 in advanced secondary hyperparathyroidismAmerican Journal of Kidney Diseases, 2004
- FGF-23 in patients with end-stage renal disease on hemodialysisKidney International, 2004
- FGF-23 Is a Potent Regulator of Vitamin D Metabolism and Phosphate HomeostasisJournal of Bone and Mineral Research, 2004
- Acute and Chronic Regulation of Thick Ascending Limb Endothelial Nitric Oxide Synthase by StatinsJournal of the American Society of Nephrology, 2004
- Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteersKidney International, 2003
- Regulation of Fibroblastic Growth Factor 23 Expression but Not Degradation by PHEXJournal of Biological Chemistry, 2003
- Fibroblast Growth Factor 23 in Oncogenic Osteomalacia and X-Linked HypophosphatemiaNew England Journal of Medicine, 2003
- Identification of a Novel Fibroblast Growth Factor, FGF-23, Preferentially Expressed in the Ventrolateral Thalamic Nucleus of the BrainBiochemical and Biophysical Research Communications, 2000